Refractory Coronary Stent Thrombosis in a Patient with Chronic Immune Thrombocytopenia on Eltrombopag

被引：0
|
作者：
Chen, Tse-Wei [1 ]
Huang, Ting-Chun [1 ,2 ]
Huang, Chen-Wei [1 ]
Liu, Ping-Yen [1 ,2 ]
机构：
[1] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Div Cardiol, Dept Internal Med, Tainan, Taiwan
[2] Natl Cheng Kung Univ, Inst Clin Med, Coll Med, Tainan, Taiwan
来源：
ACTA CARDIOLOGICA SINICA | 2021年 / 37卷 / 05期
关键词：
ITP;
D O I：
10.6515/AC5.202109_37(5).20210518A
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：542 / 545
页数：4
相关论文
共 50 条
  • [21] A lower starting dose of eltrombopag is efficacious in Japanese patients with previously treated chronic immune thrombocytopenia
    Tomiyama, Y.
    Miyakawa, Y.
    Okamoto, S.
    Katsutani, S.
    Kimura, A.
    Okoshi, Y.
    Ninomiya, H.
    Kosugi, H.
    Nomura, S.
    Ozaki, K.
    Ikeda, Y.
    Hattori, T.
    Katsura, K.
    Kanakura, Y.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (05) : 799 - 806
  • [22] Platelet activation and function during eltrombopag treatment in immune thrombocytopenia
    Haselboeck, Johanna
    Pabinger, Ingrid
    Ay, Cihan
    Koder, Silvia
    Panzer, Simon
    ANNALS OF HEMATOLOGY, 2012, 91 (01) : 109 - 113
  • [23] Health-related quality of life in children with chronic immune thrombocytopenia treated with eltrombopag in the PETIT study
    Grainger, John D.
    Blanchette, Victor S.
    Grotzinger, Kelly M.
    Roy, Anuja
    Bussel, James B.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (01) : 102 - 106
  • [24] The long-term efficacy of eltrombopag in children with immune thrombocytopenia
    Yang, Li-
    Sang, Bao-Hua
    Yang, Chun-Hui
    Xiao, Zu-Gang
    Fang, Chun-Lian
    Lv, Yu
    Li, Na
    Yang, Qing
    Chai, Shu-Min
    Tian, Xin
    Zhang, Xian-Wen
    Huang, Ti-Long
    ANNALS OF HEMATOLOGY, 2024, 103 (08) : 2721 - 2727
  • [25] Eltrombopag in immune thrombocytopenia: efficacy review and update on drug safety
    Ramon Gonzalez-Porras, Jose
    Maria Bastida, Jose
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2018, 9 (06) : 263 - 285
  • [26] Platelet activation and function during eltrombopag treatment in immune thrombocytopenia
    Johanna Haselboeck
    Ingrid Pabinger
    Cihan Ay
    Silvia Koder
    Simon Panzer
    Annals of Hematology, 2012, 91 : 109 - 113
  • [27] Romiplostim and Eltrombopag in Immune Thrombocytopenia as a Second-Line Treatment
    Bidika, Erjola
    Fayyaz, Hafsa
    Salib, Marina
    Memon, Areeba N.
    Gowda, Asavari S.
    Rallabhandi, Bhavana
    Cancarevic, Ivan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (08)
  • [28] Child with refractory thrombocytopenia born to a mother with immune thrombocytopenia
    Asatsuma, Yui
    Mukai, Takeo
    Ibi, Kyosuke
    Kakiuchi, Satsuki
    Kato, Shota
    Takahashi, Naoto
    Kato, Motohiro
    PEDIATRICS INTERNATIONAL, 2024, 66 (01)
  • [29] Addressing thrombosis concerns in immune thrombocytopenia: the role of fostamatinib in immune thrombocytopenia management
    Provan, Drew
    Thachil, Jecko
    Roman, Maria Teresa alvarez
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (1-3) : 55 - 66
  • [30] Evaluation of the procoagulant state in chronic immune thrombocytopenia before and after eltrombopag treatment-a prospective cohort study
    van Dijk, Wobke E. M.
    Poolen, Geke C.
    Huisman, Albert
    Koene, Harry R.
    Fijnheer, Rob
    Thielen, Noortje
    van Bladel, Esther R.
    van Galen, Karin P. M.
    Schutgens, Roger E. G.
    Urbanus, Rolf T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 21 (04) : 1020 - 1031
12345